Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02905994
Title Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital

acute myeloid leukemia


Cytarabine + Idarubicin + Volasertib

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.